NASDAQ · CERT

Certara, Inc.

$7.75 +$0.24 (+3.20%) 1D After hours
Charting by TradingView

Key Metrics

$1.17B
Market cap
—
P/E · TTM
$419.75M
Revenue · TTM
−$15.10M
Net income
EPS · TTM $-0.09
Dividend yield —
Free cash flow $88.88M
Beta · 1Y 1.01
EBITDA · TTM $88.51M
Gross margin —

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 16
    The stock moved +16.1% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 16
  • May 15
    From its Jan 29 high, the share price fell 52%.

    Peak close $9.26 on Jan 29; trough close $4.48 on May 15. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -52%
  • May 11
    The stock moved -18.7% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 11

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$1.17B
Enterprise value$1.31B
Shares outstanding155.6M
52-wk range$4.45 – $13.88
Avg volume · 20D1.3M
Net cash −$142.98M
Book value / share$6.30
IndustryServices-Prepackaged Software
ExchangeNASDAQ
About Certara, Inc.
IPO dateDec 11, 2020
Employees1576

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E—
P/S2.78
P/FCF13.15
EV/EBITDA14.82
EV/Sales3.12
Graham №—

Profitability

Gross —
Operating -1.2%
Net -3.6%
FCF 21.2%
ROE / ROIC -1.5% · -1.3%

Financial Health

Current ratio1.88
Quick ratio—
Debt / equity0.29
Debt / EBITDA 3.30
Net cash −$142.98M
Working capital$126.44M

Cash Flow · TTM

Operating CF $90.67M
Capex −$1.79M
Free cash flow $88.88M
Buybacks —
Dividends paid —
Shareholder yield —

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

1.7
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

—
Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings